Late morbidity and mortality in patients with hodgkin's lymphoma treated during adulthood
Endocrine System Diseases
Neoplasms, Second Primary
Among a large cohort of patients treated for HL with extensive follow-up, risk of late mortality from causes other than HL and prevalence of late medical morbidity are high. Guidelines for prevention, screening, and management of late effects in adult survivors of HL are needed.